Analyses demonstrate consistent positive signals across endpoints in AKI patientsFindings derived from post hoc analysis of 101 patients also ...
Data rarely comes in usable form. Data wrangling and exploratory data analysis are the difference between a good data science model and garbage in, garbage out. Novice data scientists sometimes have ...
Clinical Molecular Marker Testing Data Capture to Promote Precision Medicine Research Within the Cancer Research Network Correlations between real-world intermediate end points (rwTTD and time to next ...
ALLO-316 in advanced clear cell renal cell carcinoma (ccRCC): Updated results from the phase 1 TRAVERSE study. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does ...
MedPage Today on MSN
Albumin 5% cut mortality rates in sudden liver failure with other organ failure
Treatment may be an effective bridge to transplantation for acute-on-chronic liver failure ...
Data presented at ASCO showed that patients who achieved at least 80 percent KRAS G12C ctDNA clearance experienced prolonged survival.
New biomarker analyses from the phase 3 KEYNOTE-522 trial provide insights into the biological factors that may influence response to pembrolizumab plus chemotherapy in early-stage triple-negative ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results